← Back to Search

Peer Support for Diabetes (PLEASED Trial)

N/A
Waitlist Available
Led By Tricia Tang, PhD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 12 months
Awards & highlights

PLEASED Trial Summary

PLEASED is a 12-month program that aims to help South Asians with type 2 diabetes improve and sustain diabetes-related health outcomes e.g. glycemic control, quality of life...) achieved from previous short-term diabetes education program. Our goal is to provide a new generation of education and support that can be ongoing, patient-driven, and flexible to the dynamic and evolving conditions of patients' "real-word" environment and life circumstances.

Eligible Conditions
  • Diabetes

PLEASED Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Glycemic Control measured by HbA1c
Secondary outcome measures
ApoB (g/L) will be collected using venous puncture blood draw
Blood pressure (mmHg) measured by Omron BP785 monitor
Body Mass Index (kg/m2)
+7 more

PLEASED Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Peer SupportExperimental Treatment1 Intervention
Peer support intervention group: During the first 3 months of DSME, participants in the DSMS intervention group will be invited to attend 6 lifestyle change sessions delivered a 2-person peer leader team and conducted bi-weekly. Immediately following the 3 months of DSME, participants are invited to attend 9 months of weekly DSMS sessions (60-minutes per session) delivered by a Peer Leader. These sessions are designed to sustain the self-management gains achieved in the 3 months of DSME.
Group II: Wait-list ControlActive Control1 Intervention
Immediately following the 6 bi-weekly DSME sessions, participants randomized to the Wait-list control group will have completed their participation in the study.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Peer Support
2011
N/A
~4780

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,415 Previous Clinical Trials
2,466,936 Total Patients Enrolled
9 Trials studying Diabetes
283 Patients Enrolled for Diabetes
VGH and UBC Hospital FoundationOTHER
3 Previous Clinical Trials
219 Total Patients Enrolled
Tricia Tang, PhDPrincipal InvestigatorUniversity of British Columbia
1 Previous Clinical Trials
600 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~7 spots leftby Apr 2025